Bosutinib is a synthetic tyrosine kinase inhibitor (TKI) used in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It acts by targeting both Abl and Src family kinases,… Read more








![Chemical structure of 2-Cyano-N-(2,4-dichloro-5-methoxy phenyl)-3-{4-methoxy-3-[3-(4-methyl piperazin-1-yl)-propoxy]- phenylamino} acrylamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F846023-56-1-2-Cyano-N-24-dichloro-5-methoxy-phenyl-3-4-methoxy-3-3-4-methyl-piperazin-1-yl-propoxy-phenylamino-acrylamide.png&w=3840&q=75)












![Chemical structure of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6,7-dimethoxy-3-quinolinecarbonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F380843-12-9-4-24-Dichloro-5-methoxyphenylamino-67-dimethoxy-3-quinolinecarbonitrile.png&w=3840&q=75)
![Chemical structure of 4-[(2,4-Dichloro-5-methoxyphenyl)amino]-7-hydroxy-6-methoxy-3-quinolinecarbonitrile](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1460227-29-5-4-24-Dichloro-5-methoxyphenylamino-7-hydroxy-6-methoxy-3-quinolinecarbonitrile.png&w=3840&q=75)



























Bosutinib is a synthetic tyrosine kinase inhibitor (TKI) used in the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It acts by targeting both Abl and Src family kinases, thereby inhibiting the abnormal signaling that drives leukemic cell proliferation. To ensure the quality, safety, and regulatory compliance of this drug, laboratories utilize high-quality Bosutinib reference standards. This category includes the active pharmaceutical ingredient (API) alongside its pharmacopeial and non-pharmacopeial impurities, potential degradation products, and metabolites. Pharmaceutical laboratories rely on these reference materials for essential analytical tasks, including impurity profiling, method validation, and long-term stability studies. Additionally, stable isotope labelled compounds are available to provide precise internal standards for advanced mass spectrometry-based assays. By using these well-characterized standards, researchers can achieve accurate identification and quantification of related substances, supporting robust quality control throughout the drug's development and manufacturing lifecycle.